allows cytyc corp due dilligence, page-4

re: next acquisition I also believe this is possible since i am Mayne shareholder and at their yearly presentation i read that they are on prowl for oncology company . Also Sirtex has partnership with Mayne products of Oxaliplatin and Irinotecan which are in late trials as working very well with Sirtex Sir spheres in metastatic cancer to the liver. Sirtex shares look very undervalued I agree Also Oxaliplatin and Irinotecan with Sirtex Sir Sphers are billion dollar sales potential.